Lexicon Pharmaceuticals, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $61.7M | $46.6M | $203.0M | $137.3M | $37.5M | $30.4M | $186.3M | $47.2M |
| Accounts Receivable | $4.8M | $7.5M | $911.0K | $1.0M | $790.0K | $1.4M | $350.0K | $744.0K |
| Inventory | $1.9M | $0 | — | — | — | — | — | — |
| Total Current Assets | $322.0M | $357.9M | $532.4M | $369.0M | $134.6M | $230.9M | $285.8M | $214.7M |
| Property, Plant & Equipment | $17.7M | $19.4M | $21.2M | $1.1M | $41.4M | $42.6M | $46.4M | $53.4M |
| Goodwill | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M |
| Intangible Assets (Excl. Goodwill) | $23.2M | — | — | — | — | — | — | — |
| Total Assets | $436.5M | $475.6M | $652.0M | $471.4M | $274.2M | $371.8M | $430.5M | $366.9M |
| Liabilities | ||||||||
| Accounts Payable | $38.8M | $52.9M | $19.7M | $13.1M | $9.7M | $7.7M | $6.0M | $3.2M |
| Total Current Liabilities | $105.5M | $164.6M | $123.0M | $45.0M | $19.3M | $18.3M | $21.4M | $10.8M |
| Long-Term Debt | $231.6M | $85.2M | $101.0M | $87.5M | $20.2M | $21.9M | $23.5M | $27.3M |
| Total Liabilities | $368.3M | $318.2M | $366.1M | $187.4M | $104.0M | $105.1M | $132.9M | $119.9M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.37B | $-1.25B | $-1.11B | $-1.10B | $-1.00B | $-899.8M | $-789.6M | $-673.4M |
| Total Stockholders' Equity | $68.3M | $167.5M | $286.0M | $284.0M | $170.2M | $266.7M | $297.6M | $247.0M |